Bacterial multidrug resistance unrelated to multidrug exporters: cell biology insight

Area of Science:

• Microbiology
• Molecular Biology
• Genetics

Background:

• Multidrug resistance (MDR) in cancer cells was initially linked to drug efflux pumps.
• Mutagenized Escherichia coli exhibit extensive mutations conferring resistance to target inhibitors.
• Most mutants displayed multiple drug resistance, suggesting alternative resistance mechanisms.

Purpose of the Study:

• To investigate the genetic basis of multidrug resistance in Escherichia coli.
• To elucidate the role of target and ligand sequestration in conferring resistance.
• To propose a mechanism for the high efficiency of local mutagenesis in resistance gene emergence.

Main Methods:

• Genome-wide mutation mapping in Escherichia coli.
• Analysis of genetic mutations responsible for target and ligand sequestration.
• Investigating the role of gene organization and intracellular flux in mutagenesis.

Main Results:

• Mutations conferring MDR were found across the genome, not solely linked to efflux pumps.
• A specific mutant's MDR was attributed to simultaneous mutations in tightly linked, cassette-like genes.
• These mutations resulted in target and ligand sequestration, hindering drug efficacy.
• A model proposing enhanced local mutagenesis due to cassette-like gene organization and altered cytoplasm geometry was presented.

Conclusions:

• MDR in bacteria can emerge through mechanisms beyond efflux pumps, involving target and ligand sequestration.
• Tightly linked, cassette-like gene organization may promote localized, intense mutagenesis.
• Alterations in cytoplasm geometry, affecting intracellular flux, could underlie sequestration.
• This provides a novel perspective on bacterial chemoresistance evolution.